Good news for users analyzing complex sample mixtures: Shimadzu offers an extra dimension in peak separations for all hyphenation technologies in chromatography.
Good news for users analyzing complex sample mixtures: Shimadzu offers an extra dimension in peak separations for all hyphenation technologies in chromatography - no matter whether Heart-Cut MDGC, comprehensive GCxGC(qMS), LCxGC(qMS) or LCxLC(MS) analysis. Users obtain additional and more precise qualitative and quantitative information on the compounds of interest.
This breakthrough solution enables in-depth insights by Shimadzu´s unique MDGC Heart-Cut Technology transferring selected unresolved peaks into the second column. Multiple cut times are set by mouse clicks and stored in the method of MDGCsolution software. Comprehensive multidimensional technologies provide highest peak capacity, combined perfectly with the fastest quadrupole MS speed technologies marketwide. A user-friendly hardware design and instructive unique software for comprehensive qualitative and quantitative data analysis give the breakthrough in these technologies.
For more information please visit ref="http://www.shimadzu.eu">www.shimadzu.eu
GC Analysis Reveals PCB Accumulation in Antarctic Penguins and Krill
July 3rd 2025Researchers from the University of Murica (Murica, Spain), the Carlos III Health Institute (Madrid, Spain), and the University of Siena (Siena, Italy) evaluated the concentration of polychlorinated biphenyls (PCBs) in chinstrap penguins and krill from Deception Island (South Shetland Islands, Antarctica) to provide additional data of the PCB presence in Antarctica. To this end, 34 samples of different tissues corresponding to four adult specimens and six chicks were analyzed with gas chromatography.
FDA Grants Breakthrough Status to AI-Enhanced GC-MS Device for Bladder Cancer Detection
July 1st 2025A new cancer detection test to analyze volatile organic compounds through urine analysis, was granted the Breakthrough Device Designation status by the U.S. FDA. The system, which is built on gas chromatography–mass spectrometry (GC–MS) and proprietary AI, generates real-time cancer risk scores.